11. Myasthenia gravis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 332 / Drugs : 234 - (DrugBank : 81) / Drug target genes : 45 - Drug target pathways : 127
Myasthenia gravis and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
11 | Myasthenia gravis |
13 | Multiple sclerosis/Neuromyelitis optica |
46 | Malignant rheumatoid arthritis |
96 | Crohn disease |
49 | Systemic lupus erythematosus |
65 | Primary immunodeficiency |
51 | Scleroderma |
6 | Parkinson disease |
53 | Sjogren syndrome |
107 | Juvenile idiopathic arthritis |
40 | Takayasu arteritis |
28 | Systemic amyloidosis |
44 | Wegener granulomatosis |
283 | Acquired pure red cell aplasia |
60 | Aplastic anemia |
284 | Diamond-Blackfan anemia |
164 | Oculocutaneous albinism |
55 | Relapsing polychondritis |
300 | IgG4-related disease |
2 | Amyotrophic lateral sclerosis |
50 | Dermatomyositis |
285 | Fanconi anemia |
61 | Autoimmune hemolytic anemia |
162 | Pemphigoid |
41 | Giant cell arteritis |
62 | Paroxysmal nocturnal hemoglobinuria |
113 | Muscular dystrophy |
222 | Primary nephrotic syndrome |
93 | Primary biliary cholangitis |
85 | Idiopathic interstitial pneumonia |
45 | Eosinophilic granulomatosis with Polyangiitis |
169 | Menkes disease |
170 | Occipital horn syndrome |
256 | Muscle glycogenosis |
14 | Chronic inflammatory demyelinating polyneuropathy |
271 | Ankylosing spondylitis |
42 | Polyarteritis nodosa |
286 | Hereditary sideroblastic anemia |
97 | Ulcerative colitis |
95 | Autoimmune hepatitis |
226 | Interstitial cystitis with Hunners ulcer |
66 | IgA nephropathy |
19 | Lysosomal storage disease |
43 | Microscopic polyangiitis |
228 | Bronchiolitis obliterans |
118 | Myelomeningocele |
224 | Purpura nephritis |
269 | Pyogenic arthritis |
22 | Moyamoya disease |
234 | Peroxisomal disease (except Adrenoleukodystrophy) |
35 | Pemphigus |
70 | Spinal stenosis |
288 | Autoimmune acquired coagulation factor deficiency |
84 | Sarcoidosis |
26 | HTLV-1-associated myelopathy |
12 | Congenital myasthenic syndrome |
302 | Leber hereditary optic neuropathy |
5 | Progressive supranuclear palsy |
64 | Thrombotic thrombocytopenic purpura |
326 | Osteopetrosis |
58 | Hypertrophic cardiomyopathy |
158 | Tuberous sclerosis |
56 | Behcet disease |
57 | Idiopathic dilated cardiomyopathy |
151 | Rasmussen encephalitis |
331 | Idiopathic multicentric castleman disease |
38 | Stevens-Johnson syndrome |
20 | Adrenoleukodystrophy |
36 | Epidermolysis bullosa |
227 | Osler disease |
39 | Toxic epidermal necrolysis |
86 | Pulmonary arterial hypertension |
17 | Multiple system atrophy |
160 | Congenital ichthyosis |
4 | Primary lateral sclerosis |
90 | Retinitis pigmentosa |
34 | Neurofibromatosis |
299 | Cystic fibrosis |
274 | Osteogenesis Imperfecta |
280 | Huge arteriovenous malformation with cervicofacial or limb lesion |
3 | Spinal muscular atrophy |
323 | Aromatic L-amino acid decarboxylase deficiency |
206 | Fragile X syndrome |
127 | Frontotemporal lobar degeneration |
63 | Idiopathic thrombocytopenic purpura |
296 | Biliary atresia |
215 | Tetralogy of Fallot |
210 | Single Ventricle |
251 | Urea cycle disorder |
8 | Huntington disease |
78 | Hypopituitarism |
268 | Nakajo-Nishimura syndrome |
325 | Hereditary autoinflammatory syndrome |
337 | Homocystinuria |
278 | Huge lymphatic malformation with cervicofacial lesion |
16 | Crow-Fukase syndrome |
94 | Primary sclerosing cholangitis |
270 | Chronic recurrent multifocal osteomyelitis |
25 | Progressive multifocal leukoencephalopathy |
172 | Hypophosphatasia |
212 | Tricuspid atresia |
254 | Porphyria |
167 | Marfan syndrome |
21 | Mitochondrial disease |
111 | Congenital myopathy |
54 | Adult still disease |
52 | Mixed connective tissue disease |
220 | Rapidly progressive glomerulonephritis |
30 | Distal myopathy |